Slager et al. found four additional IRF8 variants associated to both decreased CLL risk and increased IRF8 expression (using lymphocytes cell lines data) which is opposite to the previous finding by Crowther et al. one year earlier [57,62]. This evidence concerns the gene IRF8 and B-cell chronic lymphocytic leukemia.